(Q36192428)

12 August 2017

Second generation antipsychotics improve sexual dysfunction in schizophrenia: a randomised controlled trial (English)

1 reference

12 August 2017

1 reference

1 reference

Karen P Hayhurst

2

0 references

Richard J. Drake

object named as

Richard J Drake

series ordinal

3

0 references

author name string

Ahmed Mahmoud

series ordinal

1

1 reference

PMC publication ID

3428616

12 August 2017

Shôn W Lewis

series ordinal

4

1 reference

12 August 2017

16 January 2011

1 reference

Schizophrenia Research and Treatment

12 August 2017

1 reference

12 August 2017

2011

1 reference

12 August 2017

596898

1 reference

Creative Commons Attribution 3.0 Unported

12 August 2017

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Sexual dysfunction: the unspoken side effect of antipsychotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428616

The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913).

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428616

Sexual dysfunction in schizophrenia: focus on recent evidence

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428616

Adverse effects of atypical antipsychotics : differential risk and clinical implications

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428616

Sexual dysfunction in schizophrenia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428616

Management of sexual dysfunction due to antipsychotic drug therapy

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428616

Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428616

Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428616

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428616

Sexuality and schizophrenia: a review

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428616

Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428616

Hyperprolactinaemia and antipsychotic therapy in schizophrenia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428616

Effects of antipsychotics on sexual and endocrine function in women: implications for clinical practice

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428616

The effects of atypical antipsychotics on serum prolactin levels

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428616

Predictors of noncompliance in patients with schizophrenia.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428616

Sexual dysfunction and antipsychotic treatment

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428616

Sexual dysfunction in patients taking conventional antipsychotic medication

1 October 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428616

1 October 2017

https://api.crossref.org/works/10.1155%2F2011%2F596898

Sulpiride for schizophrenia

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428616

Measures of quality of life among persons with severe and persistent mental disorders

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428616

Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428616

Sexual dysfunction in male schizophrenic patients.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428616

A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia

2 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F596898

Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F596898

Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F596898

Categorical prevalence and severity of hyperprolactinaemia in two UK cohorts of patients with severe mental illness during treatment with antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F596898

Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F596898

Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F596898

Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F596898

Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F596898

A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F596898

Change in sexual dysfunction with aripiprazole: a switching or add-on study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F596898

The Derogatis Interview for Sexual Functioning (DISF/DISF-SR): an introductory report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F596898

Detecting improvement in quality of life and symptomatology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F596898

Quality of life in schizophrenics with and without the deficit syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F596898

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428616

Male sexual dysfunction and quality of life in schizophrenia.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428616

Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428616

Subjective utility ratings of neuroleptics in treating schizophrenia

22 September 2018

1 reference

12 December 2020

Sexual dysfunction in patients with schizophrenia on antipsychotic medication

1 reference

12 December 2020

Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients

1 reference

12 December 2020

Sexuality and quality of life of patients with schizophrenia

1 reference

12 December 2020

Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: An empirical evaluation of olanzapine, risperidone, and quetiapine

1 reference

12 December 2020

Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence

1 reference

12 December 2020

The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome

1 reference

12 December 2020

Are sexual side effects of prolactin-raising antipsychotics reducible to serum prolactin?

1 reference

12 December 2020

Identifiers

DOI

10.1155/2011/596898

1 reference

12 August 2017

1 reference

PMC publication ID

3428616

12 August 2017

PubMed publication ID

22937269

1 reference

PMC publication ID

3428616